Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Procalcitonin To Reduce Antibiotics in Chronic Obstructive Lung Disease

NCT01950936 is registered in ClinicalTrials.gov with Danish Procalcitonin Study Group as lead sponsor.

NCT NCT01950936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01950936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Procalcitonin To Reduce Antibiotics in Chronic Obstructive Lung Disease
Lead sponsor
Danish Procalcitonin Study Group
Phase
Phase 2/3
Overall status
Completed
Start date
November 30, 2012
Completion date
September 30, 2013
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive lung disease